Subscribe

Online First

The following Value-Based Cancer Care articles are now available online ahead of print.

 Online First
Aliqopa the Newest Treatment Approved for Adults with Relapsed Follicular Lymphoma
FDA Approvals, News & Updates
December 2017, Vol 8, No 5
On September 14, 2017, the FDA granted accelerated approval to copanlisib (Aliqopa; Bayer Healthcare) for the treatment of adults with relapsed follicular lymphoma who have received ≥2 previous systemic therapies. Copanlisib received priority review and an orphan drug designation for this indication.
Read Article
 Online First
The NCCN Evidence Blocks and Clinical Practice Guidelines: Identifying Truth
By Al B. Benson III, MD; Robert W. Carlson, MD
March 2016, Vol 7, No 2
A recently published perspective in Value-Based Cancer Care criticized the National Comprehensive Cancer Network (NCCN) Evidence Blocks initiative. Regrettably, that perspective is extremely misleading and is full of innuendo and misuse of statistics.
Read Article

Page 2 of 2

  • 1
  • 2

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

Subscribe
© Amplity Health. All Rights Reserved. Privacy Policy.